Correlation Between Ono Pharmaceutical and Nabtesco

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ono Pharmaceutical and Nabtesco at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ono Pharmaceutical and Nabtesco into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ono Pharmaceutical Co and Nabtesco, you can compare the effects of market volatilities on Ono Pharmaceutical and Nabtesco and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ono Pharmaceutical with a short position of Nabtesco. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ono Pharmaceutical and Nabtesco.

Diversification Opportunities for Ono Pharmaceutical and Nabtesco

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Ono and Nabtesco is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Ono Pharmaceutical Co and Nabtesco in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nabtesco and Ono Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ono Pharmaceutical Co are associated (or correlated) with Nabtesco. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nabtesco has no effect on the direction of Ono Pharmaceutical i.e., Ono Pharmaceutical and Nabtesco go up and down completely randomly.

Pair Corralation between Ono Pharmaceutical and Nabtesco

Assuming the 90 days horizon Ono Pharmaceutical Co is expected to under-perform the Nabtesco. But the pink sheet apears to be less risky and, when comparing its historical volatility, Ono Pharmaceutical Co is 2.73 times less risky than Nabtesco. The pink sheet trades about -0.58 of its potential returns per unit of risk. The Nabtesco is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  721.00  in Nabtesco on October 11, 2024 and sell it today you would earn a total of  308.00  from holding Nabtesco or generate 42.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy47.62%
ValuesDaily Returns

Ono Pharmaceutical Co  vs.  Nabtesco

 Performance 
       Timeline  
Ono Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ono Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Nabtesco 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Nabtesco are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile forward-looking signals, Nabtesco showed solid returns over the last few months and may actually be approaching a breakup point.

Ono Pharmaceutical and Nabtesco Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ono Pharmaceutical and Nabtesco

The main advantage of trading using opposite Ono Pharmaceutical and Nabtesco positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ono Pharmaceutical position performs unexpectedly, Nabtesco can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nabtesco will offset losses from the drop in Nabtesco's long position.
The idea behind Ono Pharmaceutical Co and Nabtesco pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Valuation
Check real value of public entities based on technical and fundamental data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance